ArticleOncology letters2018

Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β-catenin signaling pathway.

Kaizhi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.